&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-11-08, 20:00

Researchers to Return to the Site of NORI’s Nodule Collection System Test to Assess Seafloor Ecosystem Function A Year After the Test
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-11-01, 18:23

Tizeti secures debt financing from NIDF to expand internet access in Nigeria
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-10-27, 23:15

Junshi Biosciences Presents 11 Clinical Trials of Toripalimab at the ESMO Congress 2023
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-10-26, 22:45

Sandoz successfully issues CHF 750 million in inaugural bonds
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-10-23, 12:00

Philips delivers strong sales growth, profitability and cash flow; raises full-year outlook
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-10-03, 23:00

Zoomtopia 2023: One platform delivering limitless human connection
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-08-18, 23:00

Bad Idea AI's $BAD: A Trailblazer in Human-AI Synergy in the Crypto Universe
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-08-17, 20:00

ÜberStrategist, a Globally Recognized Video Game, Entertainment, and Technology PR and Marketing Agency, Makes the Prestigious Inc. 5000 List for the Second Consecutive Year
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-08-01, 19:23

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-05-05, 03:05

Fortinet Reports First Quarter 2023 Financial Results
Dora Legere

Popular Posts